A systematic approach to optimize electronic health record medication alerts in a health system

被引:14
作者
Bhakta, Sunny B. [1 ,2 ]
Colavecchia, A. Carmine [1 ,2 ]
Haines, Linda [1 ]
Varkey, Divya [3 ]
Garey, Kevin W. [3 ]
机构
[1] Houston Methodist Hosp, Dept Pharm Serv, Houston, TX USA
[2] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[3] Univ Houston, Coll Pharm, Dept Pharm Practice & Translat Res, Houston, TX 77030 USA
关键词
adverse events; automation; clinical pharmacy; pharmacovigilance; CLINICAL DECISION-SUPPORT; INTERRUPTED TIME-SERIES;
D O I
10.1093/ajhp/zxz012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose The effectiveness of a systematic, streamlined approach to optimize drug-drug interaction alerts in an electronic health record for a health system was studied. Methods An 81-week quasi-experimental study was conducted to evaluate interventions made to medication-related clinical decision-support (CDS) alerts. Medication-related CDS alerts were systematically reduced using a multi disciplinary healthcare committee. The primary endpoint was weekly overall, modification, and acknowledgement rates of medication alerts after drug-drug interaction reclassification. Secondary endpoints included sub analysis of types of medication alerts (drug-drug interaction and duplicate therapy alerts) and alert use by providers (pharmacist and prescribers). Data was analyzed using interrupted time series regression analysis. Results After implementation of the new alert system, total number of weekly inpatient alerts decreased from 68,900 (66,300-70,900) and 50,300 (48,600-53,600) in the postintervention period (p < 0.001). The perentage of alerts acknowledged weekly increased from 11.8% (IQR, 11.4-12.1%) in the preintervention period to 13.7% (IQR, 13.3-14.0%) in the postintervention period (p < 0.001). The percentage of alerts that were modified also increased from 5.0% (IQR, 4.9-5.3%) in the preintervention period to 7.3% (IQR, 7.0-7.6%) in the postintervention period (p < 0.001). Both increases were primarily seen with pharmacists versus other healthcare professionals (p < 0.001). Conclusion A committee-led systematic approach to optimizing drug-drug interactions facilitated a significant decrease in the overall number of alerts and an increase in both medication alert acknowledgement and modification rates.
引用
收藏
页码:530 / 536
页数:7
相关论文
共 16 条
  • [11] Tiering Drug-Drug Interaction Alerts by Severity Increases Compliance Rates
    Paterno, Marilyn D.
    Maviclia, Saverio M.
    Gorman, Paul N.
    Seger, Diane L.
    Yoshida, Eileen
    Seger, Andrew C.
    Bates, David W.
    Gandhi, Tejal K.
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2009, 16 (01) : 40 - 46
  • [12] Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records
    Phansalkar, Shobha
    Desai, Amrita
    Choksi, Anish
    Yoshida, Eileen
    Doole, John
    Czochanski, Melissa
    Tucker, Alisha D.
    Middleton, Blackford
    Bell, Douglas
    Bates, David W.
    [J]. BMC MEDICAL INFORMATICS AND DECISION MAKING, 2013, 13
  • [13] Rose E., 2008, The pharmacy informatic primer, P46
  • [14] Recommendations for selecting drug-drug interactions for clinical decision support
    Tilson, Hugh
    Hines, Lisa E.
    McEvoy, Gerald
    Weinstein, David M.
    Hansten, Philip D.
    Matuszewski, Karl
    le Comte, Marianne
    Higby-Baker, Stefanie
    Hanlon, Joseph T.
    Pezzullo, Lynn
    Vieson, Kathleen
    Helwig, Amy L.
    Huang, Shiew-Mei
    Perre, Anthony
    Bates, David W.
    Poikonen, John
    Wittie, Michael A.
    Grizzle, Amy J.
    Brown, Mary
    Malone, Daniel C.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (08) : 576 - 585
  • [15] Improving medication-related clinical decision support
    Tolley, Clare L.
    Slight, Sarah P.
    Husband, Andrew K.
    Watson, Neil
    Bates, David W.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (04) : 239 - 246
  • [16] Segmented regression analysis of interrupted time series studies in medication use research
    Wagner, AK
    Soumerai, SB
    Zhang, F
    Ross-Degnan, D
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (04) : 299 - 309